# Trade Mark Journal No.2026/011 13 March 2026

## WO0000001893405 (42)

Office of origin: United States of America

Date of International Registration:26 November 2025
Date of designation in the UK: 26 November 2025

Protection of this designation shall give no exclusive rights to the term "MOLECULAR THERAPEUTICS"

International priority date claimed: 31 May 2025 (United States of America) (99211669)

Class 42
  Pharmaceutical research and development; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of pharmaceutical preparations; research and development in the field of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; testing, inspection, research, or development of pharmaceutical preparations for gene therapy.

4D MOLECULAR THERAPEUTICS INC.

Representative: Edwin Coe LLP, 2 Stone Buildings, Lincoln's Inn London WC2A 3TH UNITED KINGDOM